Abstract:BACKGROUND & AIMS: Visceral smooth muscle cells (SMCs) are an integral component of the gastrointestinal (GI) tract that regulate GI motility. SMC contraction is regulated by post-translational signaling and the state of differentiation. Impaired SMC contraction is associated with significant morbidity and mortality, but the mechanisms regulating SMC-specific contractile gene expression, including the role of long noncoding RNAs (lncRNAs), remain largely unexplored. Herein, we reveal a critical role of Carmn (cardiac mesoderm enhancer-associated noncoding RNA), an SMC-specific lncRNA, in regulating visceral SMC phenotype and contractility of the GI tract. METHODS: Genotype-Tissue Expression and publicly available single-cell RNA sequencing (scRNA-seq) data sets from embryonic, adult human, and mouse GI tissues were interrogated to identify SMC-specific lncRNAs. The functional role of Carmn was investigated using novel green fluorescent protein (GFP) knock-in (KI) reporter/knock-out (KO) mice. Bulk RNA-seq and single nucleus RNA sequencing (snRNA-seq) of colonic muscularis were used to investigate underlying mechanisms. RESULTS: Unbiased in silico analyses and GFP expression patterns in Carmn GFP KI mice revealed that Carmn is highly expressed in GI SMCs in humans and mice. Premature lethality was observed in global Carmn KO and inducible SMC-specific KO mice due to GI pseudo-obstruction and severe distension of the GI tract, with dysmotility in cecum and colon segments. Histology, GI transit, and muscle myography analysis revealed severe dilation, significantly delayed GI transit, and impaired GI contractility in Carmn KO vs control mice. Bulk RNA-seq of GI muscularis revealed that loss of Carmn promotes SMC pheno-typic switching, as evidenced by up-regulation of extracellular matrix genes and down-regulation of SMC contractile genes, including Mylk, a key regulator of SMC contraction. snRNA-seq further revealed SMC Carmn KO not only compromised myogenic motility by reducing contractile gene expression but also impaired neurogenic motility by disrupting cell-cell con-nectivity in the colonic muscularis. These findings may have translational significance, because silencing CARMN in human colonic SMCs significantly attenuated contractile gene expres-sion, including MYLK, and decreased SMC contractility. Lucif-erase reporter assays showed that CARMN enhances the transactivation activity of the master regulator of SMC contractile phenotype, myocardin, thereby maintaining the GI SMC myogenic program. CONCLUSIONS: Our data suggest that Carmn is indispensable for maintaining GI SMC contractile function in mice and that loss of function of CARMN may contribute to human visceral myopathy. To our knowledge this is the first study showing an essential role of lncRNA in the regulation of visceral SMC phenotype.

Discovery of an Evolutionarily Conserved Smooth Muscle Cell-Specific Lncrna CARMN

Discovery of an evolutionarily conserved smooth muscle cell-specific lncRNA<i>CARMN</i>

CARMN is an Evolutionarily Conserved Smooth Muscle Cell-Specific LncRNA That Maintains Contractile Phenotype by Binding Myocardin

The Long Noncoding RNA Cardiac Mesoderm Enhancer- Associated Noncoding RNA (carmn) is a Critical Regulator of Gastrointestinal Smooth Muscle Contractile Function and Motility

Exploring the Spectrum of Long Non-Coding RNA CARMN in Physiological and Pathological Contexts

Identification and Functional Prediction of Long Non-Coding RNAs in Dilated Cardiomyopathy by Bioinformatics Analysis

Analysis of Changes in Circular RNA Expression and Construction of Cerna Networks in Human Dilated Cardiomyopathy.

LncCMRR Plays an Important Role in Cardiac Differentiation by Regulating the Purb/Flk1 Axis.

CARMN Loss Regulates Smooth Muscle Cells and Accelerates Atherosclerosis in Mice

Macrophage-mediated downregulation of lncRNA Carmn in mouse abdominal aortic aneurysm

Abstract P125: RNA Sequencing of Left-ventricular Tissue Highlights Novel Pathways Impacted by the Loss of Mir-146B-5p in a Rat Model of Chronic Kidney Disease

Discovery of Transacting Long Noncoding RNAs That Regulate Smooth Muscle Cell Phenotype

MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation

Screening lncRNAs essential for cardiomyocyte proliferation by integrative profiling of lncRNAs and mRNAs associated with heart development

Abstract 91: Genome-wide Identification and Characterization of Cardiac Hypertrophy-related Long Noncoding RNAs in Mice

Mef2c- and Nkx2-5-Divergent Transcriptional Regulation of Chick WT1_76127 and Mouse Gm14014 lncRNAs and Their Implication in Epicardial Cell Migration

Long noncoding RNAs C2dat1 enhances vascular smooth muscle cell proliferation and migration by targeting MiR‐34a‐5p

Epigenetic Regulation of Cardiomyocyte Maturation by Arginine Methyltransferase CARM1

Abstract 009: Ribosomal Profiling of Vascular Smooth Muscle Cells in Vivo Identifies Cell-type Specific Transcripts and Enrichment of Blood Pressure Associated Genes

AK098656, a Novel Vascular Smooth Muscle Cell-Dominant Long Noncoding RNA, Promotes Hypertension

Differential Expression Profile of Long Non-Coding Rnas During Differentiation of Cardiomyocytes